The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 6014-6023

  Gottar Guillier, Marie ^a   Dodeller, Francis ^a,d   Huesken, Dieter ^a   Iourgenko, Vadim ^b   Mickanin, Craig ^b   Labow, Mark ^b   Gaveriaux, Samuel ^a   Kinzel, Bernd ^a   Mueller, Matthias ^a   Alitalo, Kari ^c   Littlewood Evans, Amanda ^a   Cenni, Bruno ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c BIOMEDICUM HELSINKI   (Finland)

^d MORPHOSYS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BONE MARROW KINASE ON CHROMOSOME X; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 BINDING PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CATALYSIS; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPISTASIS; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYRISTYLATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ARTHRITIS; BLOOD PROTEINS; CELL LINE; DISEASE MODELS, ANIMAL; HELA CELLS; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-1BETA; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTORS;

EID: 79956223769     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002813     Document Type: Article

References (64)

1. Brennan, F. M., and I. B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118: 3537-3545.
2. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411-452.
3. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65. (Pubitemid 36511832)
4. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132: 344-362.
5. Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NFkappaB transcription factors in the immune system. Annu. Rev. Immunol. 27: 693-733.
6. Sakurai, H., H. Miyoshi, W. Toriumi, and T. Sugita. 1999. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J. Biol. Chem. 274: 10641-10648.
7. Shim, J. H., C. Xiao, A. E. Paschal, S. T. Bailey, P. Rao, M. S. Hayden, K. Y. Lee, C. Bussey, M. Steckel, N. Tanaka, et al. 2005. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19: 2668-2681. (Pubitemid 41627934)
8. Moriguchi, T., N. Kuroyanagi, K. Yamaguchi, Y. Gotoh, K. Irie, T. Kano, K. Shirakabe, Y. Muro, H. Shibuya, K. Matsumoto, et al. 1996. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271: 13675-13679.
9. Shirakabe, K., K. Yamaguchi, H. Shibuya, K. Irie, S. Matsuda, T. Moriguchi, Y. Gotoh, K. Matsumoto, and E. Nishida. 1997. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272: 8141-8144.
10. Tamagnone, L., I. Lahtinen, T. Mustonen, K. Virtaneva, F. Francis, F. Muscatelli, R. Alitalo, C. I. Smith, C. Larsson, and K. Alitalo. 1994. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 9: 3683-3688.
11. Mano, H. 1999. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Factor Rev. 10: 267-280. (Pubitemid 30041404)
12. Weil, D., M. A. Power, S. I. Smith, and C. L. Li. 1997. Predominant expression of murine Bmx tyrosine kinase in the granulo-monocytic lineage. Blood 90: 4332-4340.
13. Kaukonen, J., I. Lahtinen, S. Laine, K. Alitalo, and A. Palotie. 1996. BMX tyrosine kinase gene is expressed in granulocytes and myeloid leukaemias. Br. J. Haematol. 94: 455-460.
14. Ekman, N., A. Lymboussaki, I. Västrik, K. Sarvas, A. Kaipainen, and K. Alitalo. 1997. Bmx tyrosine kinase is specifically expressed in the endocardium and the endothelium of large arteries. Circulation 96: 1729-1732. (Pubitemid 27400725)
15. Guo, L., Y. Guo, and S. Xiao. 2008. Expression of Etk/Bmx tyrosine kinase in intrahepatic cholangiocarcinoma. J. Surg. Oncol. 97: 428-432.
16. Guo, L., Y. Guo, and S. Xiao. 2007. Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma. Oncology 72: 410-416. (Pubitemid 351238157)
17. Dai, B., O. Kim, Y. Xie, Z. Guo, K. Xu, B. Wang, X. Kong, J. Melamed, H. Chen, C. J. Bieberich, et al. 2006. Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse. Cancer Res. 66: 8058-8064. (Pubitemid 44299171)
18. Côté, J. F., A. B. Motoyama, J. A. Bush, and K. Vuori. 2005. A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling. Nat. Cell Biol. 7: 797-807.
19. Andreotti, A. H., S. C. Bunnell, S. Feng, L. J. Berg, and S. L. Schreiber. 1997. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 385: 93-97.
20. Laederach, A., K. W. Cradic, K. N. Brazin, J. Zamoon, D. B. Fulton, X. Y. Huang, and A. H. Andreotti. 2002. Competing modes of self-association in the regulatory domains of Bruton's tyrosine kinase: intramolecular contact versus asymmetric homodimerization. Protein Sci. 11: 36-45.
21. Abassi, Y. A., M. Rehn, N. Ekman, K. Alitalo, and K. Vuori. 2003. p130Cas Couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. J. Biol. Chem. 278: 35636-35643.
22. Chen, R., O. Kim, M. Li, X. Xiong, J. L. Guan, H. J. Kung, H. Chen, Y. Shimizu, and Y. Qiu. 2001. Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat. Cell Biol. 3: 439-444.
23. Zhang, R., Y. Xu, N. Ekman, Z. Wu, J. Wu, K. Alitalo, and W. Min. 2003. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J. Biol. Chem. 278: 51267-51276.
24. Rajantie, I., N. Ekman, K. Iljin, E. Arighi, Y. Gunji, J. Kaukonen, A. Palotie, M. Dewerchin, P. Carmeliet, and K. Alitalo. 2001. Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium. Mol. Cell. Biol. 21: 4647-4655.
25. He, Y., Y. Luo, S. Tang, I. Rajantie, P. Salven, M. Heil, R. Zhang, D. Luo, X. Li, H. Chi, et al. 2006. Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J. Clin. Invest. 116: 2344-2355.
26. Jones, D., Z. Xu, H. Zhang, Y. He, M. S. Kluger, H. Chen, and W. Min. 2010. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis. Arterioscler. Thromb. Vasc. Biol. 30: 2553-2561.
27. Mitchell-Jordan, S. A., T. Holopainen, S. Ren, S. Wang, S. Warburton, M. J. Zhang, K. Alitalo, Y. Wang, and T. M. Vondriska. 2008. Loss of Bmx nonreceptor tyrosine kinase prevents pressure overload-induced cardiac hypertrophy. Circ. Res. 103: 1359-1362.
28. Bry, M., R. Kivelä, T. Holopainen, A. Anisimov, T. Tammela, J. Soronen, J. Silvola, A. Saraste, M. Jeltsch, P. Korpisalo, et al. 2010. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 122: 1725-1733.
29. Palmer, C. D., B. E. Mutch, T. H. Page, N. J. Horwood, and B. M. Foxwell. 2008. Bmx regulates LPS-induced IL-6 and VEGF production via mRNA stability in rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 370: 599-602.
30. Palmer, C. D., B. E. Mutch, S. Workman, J. P. McDaid, N. J. Horwood, and B. M. Foxwell. 2008. Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NFkappB activity. Blood 111: 1781-1788.
31. Semaan, N., G. Alsaleh, J. E. Gottenberg, D. Wachsmann, and J. Sibilia. 2008. Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways. J. Immunol. 180: 3485-3491.
32. Paavonen, K., N. Ekman, M. Wirzenius, I. Rajantie, M. Poutanen, and K. Alitalo. 2004. Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing. Mol. Biol. Cell 15: 4226-4233.
33. Huesken, D., J. Lange, C. Mickanin, J. Weiler, F. Asselbergs, J. Warner, B. Meloon, S. Engel, A. Rosenberg, D. Cohen, et al. 2005. Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 23: 995-1001.
34. Mukherji, M., R. Bell, L. Supekova, Y. Wang, A. P. Orth, S. Batalov, L. Miraglia, D. Huesken, J. Lange, C. Martin, et al. 2006. Genome-wide functional analysis of human cell-cycle regulators. Proc. Natl. Acad. Sci. USA 103: 14819-14824.
35. Rines, D. R., M. A. Gomez-Ferreria, Y. Zhou, P. DeJesus, S. Grob, S. Batalov, M. Labow, D. Huesken, C. Mickanin, J. Hall, et al. 2008. Whole genome functional analysis identifies novel components required for mitotic spindle integrity in human cells. Genome Biol. 9: R44.
36. Kouskoff, V., A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811-822. (Pubitemid 26404281)
37. Monach, P. A., D. Mathis, and C. Benoist. 2008. The K/BxN arthritis model. Curr. Protoc. Immunol. Chapter 15, Unit 15.22.
38. Takaesu, G., R. M. Surabhi, K. J. Park, J. Ninomiya-Tsuji, K. Matsumoto, and R. B. Gaynor. 2003. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J. Mol. Biol. 326: 105-115.
39. Blonska, M., P. B. Shambharkar, M. Kobayashi, D. Y. Zhang, H. Sakurai, B. Su, and X. Lin. 2005. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. J. Biol. Chem. 280: 43056-43063.
40. Hsu, H. L., J. N. Huang, H. B. Shu, V. Baichwal, and D. V. Goeddel. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4: 387-396.
41. Lee, T. H., J. Shank, N. Cusson, and M. A. Kelliher. 2004. The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem. 279: 33185-33191.
42. Lee, T. H., Q. J. Huang, S. Oikemus, J. Shank, J. J. Ventura, N. Cusson, R. R. Vaillancourt, B. Su, R. J. Davis, and M. A. Kelliher. 2003. The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase. Mol. Cell. Biol. 23: 8377-8385.
43. Yuasa, T., S. Ohno, J. H. Kehrl, and J. M. Kyriakis. 1998. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273: 22681-22692.
44. Shibuya, H., K. Yamaguchi, K. Shirakabe, A. Tonegawa, Y. Gotoh, N. Ueno, K. Irie, E. Nishida, and K. Matsumoto. 1996. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272: 1179-1182.
45. Tanaka, A., C. P. Gibbs, R. R. Arthur, S. K. Anderson, H. J. Kung, and D. J. Fujita. 1987. DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes. Mol. Cell. Biol. 7: 1978-1983.
46. Pan, S., P. An, R. Zhang, X. He, G. Yin, and W. Min. 2002. Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis. Mol. Cell. Biol. 22: 7512-7523.
47. Li, T. J., S. Tsukada, A. Satterthwaite, M. H. Havlik, H. Park, K. Takatsu, and O. N. Witte. 1995. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2: 451-460.
48. Li, T. J., D. J. Rawlings, H. Park, R. M. Kato, O. N. Witte, and A. B. Satterthwaite. 1997. Constitutive membrane association potentiates activation of Bruton tyrosine kinase. Oncogene 15: 1375-1383.
49. Argast, G. M., N. Fausto, and J. S. Campbell. 2005. Inhibition of RIP2/RIck/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK. Mol. Cell. Biochem. 268: 129-140.
50. Godl, K., J. Wissing, A. Kurtenbach, P. Habenberger, S. Blencke, H. Gutbrod, K. Salassidis, M. Stein-Gerlach, A. Missio, M. Cotten, and H. Daub. 2003. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc. Natl. Acad. Sci. USA 100: 15434-15439.
51. Bain, J., L. Plater, M. Elliott, N. Shpiro, C. J. Hastie, H. McLauchlan, I. Klevernic, J. S. Arthur, D. R. Alessi, and P. Cohen. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408: 297-315.
52. Tomlinson, M. G., T. Kurosaki, A. E. Berson, G. H. Fujii, J. A. Johnston, and J. B. Bolen. 1999. Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk. J. Biol. Chem. 274: 13577-13585.
53. Ellmeier, W., S. Jung, M. J. Sunshine, F. Hatam, Y. Xu, D. Baltimore, H. Mano, and D. R. Littman. 2000. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J. Exp. Med. 192: 1611-1624.
54. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
55. Pincheira, R., A. F. Castro, O. N. Ozes, P. S. Idumalla, and D. B. Donner. 2008. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J. Immunol. 181: 1288-1298.
56. Takada, Y., and B. B. Aggarwal. 2004. TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis. J. Immunol. 173: 1066-1077. (Pubitemid 38924281)
57. Mishra, S., R. Mathur, and A. W. Hamburger. 1994. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors. Lymphokine Cytokine Res. 13: 77-83.
58. Haas, T. L., C. H. Emmerich, B. Gerlach, A. C. Schmukle, S. M. Cordier, E. Rieser, R. Feltham, J. Vince, U. Warnken, T. Wenger, et al. 2009. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36: 831-844.
59. Väliaho, J., C. I. Smith, and M. Vihinen. 2006. BTKbase: the mutation database for X-linked agammaglobulinemia. Hum. Mutat. 27: 1209-1217.
60. Middendorp, S., G. M. Dingjan, A. Maas, K. Dahlenborg, and R. W. Hendriks. 2003. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity. J. Immunol. 171: 5988-5996.
61. Pan, Z., H. Scheerens, S. J. Li, B. E. Schultz, P. A. Sprengeler, L. C. Burrill, R. V. Mendonca, M. D. Sweeney, K. C. Scott, P. G. Grothaus, et al. 2007. Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase. ChemMedChem 2: 58-61.
62. Van den Berg, W. B. 2002. Lessons from animal models of arthritis. Curr. Rheumatol. Rep. 4: 232-239.
63. Lens, J. W., W. B. van den Berg, and L. B. van de Putte. 1984. Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: studies on the characteristics of and mechanisms involved in the reaction. Clin. Exp. Immunol. 55: 287-294.
64. Dumonde, D. C., and L. E. Glynn. 1962. The production of arthritis in rabbits by an immunological reaction to fibrin. Br. J. Exp. Pathol. 43: 373-383.